Prime Medicine, Inc. (PRME)

Prime Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	91.88	182.48	41.57	187.62	185.42	36.98
Short-Term Investments	52.38	7.97	80.09	106.3	84.2	16.35
Cash & Short-Term Investments	144.26	190.44	121.67	293.92	269.62	53.33
Cash Growth	-31.54%	56.53%	-58.61%	9.01%	405.59%	516.72%
Prepaid Expenses	2.95	6.78	19.06	2.45	0.96	0.07
Other Current Assets	16.54	14.67	2.25	0.25	-	-
Total Current Assets	163.77	211.89	142.98	296.62	270.58	53.4
Property, Plant & Equipment	150.34	71.56	36.6	48.55	15.68	0.6
Other Long-Term Assets	14.06	14.06	14.28	15.14	15.6	0.79
Total Assets	328.16	297.51	193.85	360.31	301.86	54.78
Accounts Payable	10.03	11.35	19.54	4.33	1.44	0.25
Accrued Expenses	6.16	11.82	10.23	9.02	36.19	0.74
Short-Term Debt	-	-	-	-	-	17.52
Current Portion of Leases	6.86	3.61	9.28	11.69	7.34	-
Current Unearned Revenue	8.21	7.09	-	-	-	-
Other Current Liabilities	3.04	4.08	17.38	1.67	13.02	0.93
Total Current Liabilities	34.29	37.96	56.42	26.71	57.98	19.44
Long-Term Leases	114.29	37.18	4.36	17.05	3.07	-
Long-Term Unearned Revenue	60.66	63.22	-	-	-	-
Long-Term Deferred Tax Liabilities	-	-	-	0.28	1.24	1.87
Other Long-Term Liabilities	12	6	-	-	-	-
Total Liabilities	221.24	144.36	60.78	44.04	62.3	21.31
Common Stock	0	0	0	0	-	-
Additional Paid-In Capital	846.04	840.36	624.41	609.85	15.16	8.35
Retained Earnings	-739.1	-687.21	-491.33	-293.2	-171.38	-6.01
Comprehensive Income & Other	-0.02	0	-0.02	-0.38	-0.03	-
Total Common Equity	106.92	153.15	133.07	316.27	-156.24	2.34
Shareholders' Equity	106.92	153.15	133.07	316.27	239.56	33.47
Total Liabilities & Equity	328.16	297.51	193.85	360.31	301.86	54.78
Total Debt	121.15	40.79	13.63	28.75	10.41	17.52
Net Cash (Debt)	23.11	149.65	108.03	265.18	259.21	35.81
Net Cash Growth	-86.16%	38.52%	-59.26%	2.30%	623.80%	314.17%
Net Cash Per Share	0.18	1.26	1.19	7.82	19.98	13.57
Filing Date Shares Outstanding	127.82	127.66	115.2	88.4	17.06	24.32
Total Common Shares Outstanding	127.69	127.66	92.64	88.36	17.06	24.32
Working Capital	129.48	173.93	86.55	269.9	212.6	33.96
Book Value Per Share	0.84	1.20	1.44	3.58	-9.16	0.10
Tangible Book Value	106.92	153.15	133.07	316.27	-156.24	2.34
Tangible Book Value Per Share	0.84	1.20	1.44	3.58	-9.16	0.10
Machinery	30.9	29.29	24.16	19.67	5.42	0.64
Construction In Progress	1.08	3.58	5.4	1.61	-	-
Leasehold Improvements	8.27	5.14	0.58	0.56	0.13	-

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q